David H. Deming's most recent trade in Phio Pharmaceuticals Corp was a trade of 23,800 Common Stock, $.0001 par value done . Disclosure was reported to the exchange on Feb. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phio Pharma Corp | David H. Deming | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 23,800 | 37,800 (2%) | 1% | 0 | Common Stock, $.0001 par value | |
| Phio Pharma Corp | Deming H. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 14,000 | 14,000 (0%) | 0% | 0 | Common Stock, $.0001 par value |